Ladan Teimoori-Toolabi

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Venues

Journal of biomolecular structure & dynamics

Journal of molecular modeling

Molecular biology reports

PLoS computational biology

Pasteur Institute of Iran

Tehran University of Medical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pasteur Institute of Iran

Iran

Associate Professor :: Molecular Medicine

Education History

Tehran University of Medical Sciences

Iran

PHD

Publications

Behzad Shahbazi, Ladan Mafakher, Seyed Shahriar Arab, Ladan Teimoori-Toolabi
Kallistatin as an inhibitory protein against colorectal cancer cells through binding to LRP6. Journal of biomolecular structure & dynamics (2023)
Mansour Poorebrahim, Mohammad Foad Abazari, Leila Moradi, Behzad Shahbazi, Reza Mahmoudi, Hourieh Kalhor, Hassan Askari, Ladan Teimoori-Toolabi
Multi-targeting of K-Ras domains and mutations by peptide and small molecule inhibitors. PLoS computational biology 18 (4) (2022)
Masoumeh Kiani-Zadeh, Mohammad Reza Rezvany, Soodeh Namjoo, Mahmood Barati, Mohammad Hossein Mohammadi, Bahare Ghasemi, Tahere Tabatabaei, Ardeshir Ghavamzadeh, Farhad Zaker, Ladan Teimoori-Toolabi
Studying the potential of upregulated PTGS2 and VEGF-C besides hyper-methylation of PTGS2 promoter as biomarkers of Acute myeloid leukemia. Molecular biology reports 49 (8) (2022)
Behzad Shahbazi, Ladan Mafakher, Ladan Teimoori-Toolabi
Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study. Journal of molecular modeling 28 (4) (2022)
Behzad Shahbazi, Seyed-Shahryar Arab, Ladan Mafakher, Kayhan Azadmansh, Ladan Teimoori-Toolabi
Computational assessment of pigment epithelium-derived factor as an anti-cancer protein during its interaction with the receptors. Journal of biomolecular structure & dynamics (2022)
Ladan Mafakher, Elham Rismani, Hamzeh Rahimi, Maryam Enayatkhani, Kayhan Azadmanesh, Ladan Teimoori-Toolabi
Computational design of antagonist peptides based on the structure of secreted frizzled-related protein-1 (SFRP1) aiming to inhibit Wnt signaling pathway. Journal of biomolecular structure & dynamics (2020)
Fatemeh Khatami, Bagher Larijani, Ramin Heshmat, Shirzad Nasiri, Mohammad Haddadi-Aghdam, Ladan Teimoori-Toolabi, Seyed M Tavangar
Hypermethylated RASSF1 and SLC5A8 promoters alongside BRAFV600E mutation as biomarkers for papillary thyroid carcinoma. Journal of cellular physiology 235 (10) (2020)
Maryam Enayatkhani, Mona Salimi, Kayhan Azadmanesh, Ladan Teimoori-Toolabi
In-silico identification of new inhibitors for Low-density lipoprotein receptor-related protein6 (LRP6). Journal of biomolecular structure & dynamics (2020)
Mansour Poorebrahim, Solmaz Sadeghi, Marzieh Ghanbarian, Hourieh Kalhor, Amirhosein Mehrtash, Ladan Teimoori-Toolabi
Identification of candidate genes and miRNAs for sensitizing resistant colorectal cancer cells to oxaliplatin and irinotecan. Cancer chemotherapy and pharmacology 85 (1) (2019)

Ladan Teimoori-Toolabi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ladan Teimoori-Toolabi